Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics.

Tonelli, M; Zingoni, M; Bacci, E; Dente, F L; Di Franco, A; Giannini, D; Taccola, M; Vagaggini, B; Paggiaro, P L

Tonelli, M; Zingoni, M; Bacci, E; Dente, F L; Di Franco, A; Giannini, D; Taccola, M; Vagaggini, B; Paggiaro, P L.

Affiliation

Tonelli M; Cardiothoracic Department, Respiratory Pathophysiology, University of Pisa, Ospedale di Cisanello, via Paradisa 2, Pisa 56100, Italy.

Pulm Pharmacol Ther ; 16(4): 237-40, 2003.

Article in En | MEDLINE | ID: mdl-12850127

Subject(s)

Acetates/therapeutic use; Anti-Asthmatic Agents/therapeutic use; Asthma/drug therapy; Leukotriene Antagonists/therapeutic use; Quinolines/therapeutic use; Tosyl Compounds/therapeutic use; Cyclopropanes; Female; Humans; Indoles; Lung Volume Measurements; Male; Middle Aged; Phenylcarbamates; Sulfides; Sulfonamides; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Asthma / Tosyl Compounds / Anti-Asthmatic Agents / Leukotriene Antagonists / Acetates Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Pulm Pharmacol Ther Year: 2003 Document type: Article

Search on Google

XML

PubMed Links